<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04394897</url>
  </required_header>
  <id_info>
    <org_study_id>Bezmialem VU</org_study_id>
    <nct_id>NCT04394897</nct_id>
  </id_info>
  <brief_title>Total Intravenous Anesthesia With Remifentanil-propofol Admixture</brief_title>
  <official_title>Total Intravenous Anesthesia With Remifentanil-propofol Admixture Using Single-infusion Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Application of total intravenous anesthesia (TIVA) may be considered as
      unpractical when compared with inhalational anesthesia. Although it is mostly not
      recommended, mixing intravenous agents seems to be popular in clinical practice. The aim of
      the study was to investigate the possible clinical drawbacks of using remifentanil-propofol
      admixture (MIXTIVA) for TIVA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ASA I-II adult patients scheduled for elective thyroidectomy were randomly allocated into 3
      groups (n= 32 for each) to have TIVA either with remifentanil and propofol infusions
      separately (control group, Group I) or with MIXTIVA infusion that had remifentanil/propofol
      proportion 2/1000 or 3/1000 (remifentanil concentration 20 µg/ml or 30 µg/ml in propofol 1%,
      Group II or Group III respectively).

      This technique may be considered as a practical implementation for busy ambulatory surgery
      centers performing general anesthesia, but delayed recovery may be predicted with longer
      duration of surgery and anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 12, 2013</start_date>
  <completion_date type="Actual">April 12, 2014</completion_date>
  <primary_completion_date type="Actual">April 12, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate Changes</measure>
    <time_frame>During the application of TIVA</time_frame>
    <description>Bradycardia: heart rate &lt;45 beat per / min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Pressure Changes</measure>
    <time_frame>During the application of TIVA</time_frame>
    <description>Hypotension (MAP &lt;60 mmHg), Hypertension( systolic arterial pressure &gt;150 mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bispectral Index (BIS) Changes</measure>
    <time_frame>During the application of TIVA</time_frame>
    <description>BIS levels &gt;60</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">96</enrollment>
  <condition>Total Intravenous Anesthesia</condition>
  <condition>Propofol</condition>
  <condition>Remifentanil</condition>
  <condition>Bispectral Index Monitoring</condition>
  <arm_group>
    <arm_group_label>TIVA</arm_group_label>
    <description>TIVA either with remifentanil and propofol infusions separately</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MIXTIVA 2/1000</arm_group_label>
    <description>MIXTIVA infusion that had remifentanil/propofol proportion 2/1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MIXTIVA 3/1000</arm_group_label>
    <description>MIXTIVA infusion that had remifentanil/propofol proportion 3/1000</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Remifentanil-Propofol admixture</intervention_name>
    <arm_group_label>MIXTIVA 2/1000</arm_group_label>
    <arm_group_label>MIXTIVA 3/1000</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ASA I-II adult patients scheduled for elective thyroidectomy were randomly allocated into 3
        groups (n= 32 for each)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        American Society of Anesthesiologists (ASA) physical status I patients American Society of
        Anesthesiologists (ASA) physical status II patients

        Exclusion Criteria:

        American Society of Anesthesiologists (ASA) physical status III patients or above patients
        A body mass index &gt;35 kg/m2 Pregnant patients Breast-feeding Menstruating women Patients
        who were not euthyroid Uncontrolled hypertension Hepatic, renal or cardiac insufficiency
        Alcohol, opioid or drug abuse Allergy or contraindication to any of the study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Anderson BJ, Bagshaw O. Practicalities of Total Intravenous Anesthesia and Target-controlled Infusion in Children. Anesthesiology. 2019 Jul;131(1):164-185. doi: 10.1097/ALN.0000000000002657. Review.</citation>
    <PMID>30920966</PMID>
  </reference>
  <reference>
    <citation>Errando CL, Sigl JC, Robles M, Calabuig E, García J, Arocas F, Higueras R, Del Rosario E, López D, Peiró CM, Soriano JL, Chaves S, Gil F, García-Aguado R. Awareness with recall during general anaesthesia: a prospective observational evaluation of 4001 patients. Br J Anaesth. 2008 Aug;101(2):178-85. doi: 10.1093/bja/aen144. Epub 2008 May 30.</citation>
    <PMID>18515816</PMID>
  </reference>
  <reference>
    <citation>Roberts FL, Dixon J, Lewis GT, Tackley RM, Prys-Roberts C. Induction and maintenance of propofol anaesthesia. A manual infusion scheme. Anaesthesia. 1988 Mar;43 Suppl:14-7.</citation>
    <PMID>3259089</PMID>
  </reference>
  <reference>
    <citation>Lamperti M. Adult procedural sedation: an update. Curr Opin Anaesthesiol. 2015 Dec;28(6):662-7. doi: 10.1097/ACO.0000000000000244. Review.</citation>
    <PMID>26356290</PMID>
  </reference>
  <reference>
    <citation>Weatherall A, Venclovas R. Experience with a propofol-ketamine mixture for sedation during pediatric orthopedic surgery. Paediatr Anaesth. 2010 Nov;20(11):1009-16. doi: 10.1111/j.1460-9592.2010.03420.x.</citation>
    <PMID>20964766</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

